Endogenous APP accumulates in synapses after BACE1 inhibition

Neuroscience Research
Saket Milind NigamLennart Brodin

Abstract

BACE1-mediated cleavage of APP is a pivotal step in the production of the Alzheimer related Aβ peptide and inhibitors of BACE1 are currently in clinical development for the treatment of Alzheimer disease (AD). While processing and trafficking of APP has been extensively studied in non-neuronal cells, the fate of APP at neuronal synapses and in response to reduced BACE1 activity has not been fully elucidated. Here we examined the consequence of reduced BACE1 activity on endogenous synaptic APP by monitoring N- and C-terminal APP epitopes by immunocytochemistry. In control rodent primary hippocampal neuron cultures, labeling with antibodies directed to N-terminal APP epitopes showed a significant overlap with synaptic vesicle markers (SV2 or synaptotagmin). In contrast, labeling with antibodies directed to C-terminal epitopes of APP showed only a limited overlap with these proteins. In neurons derived from BACE1-deficient mice, and in control neurons treated with a BACE1 inhibitor, both the N-terminal and the C-terminal APP labeling overlapped significantly with synaptic vesicle markers. Moreover, BACE1 inhibition increased the proximity between the APP C-terminus and SV2 as shown by a proximity ligation assay. These results, tog...Continue Reading

References

Apr 24, 2008·Proceedings of the National Academy of Sciences of the United States of America·Joel JakobssonLennart Brodin
Jul 16, 2008·Methods : a Companion to Methods in Enzymology·Ola SöderbergUlf Landegren
Aug 30, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Hui WangHey-Kyoung Lee
May 11, 2011·PloS One·Teja W GroemerJürgen Klingauf
Aug 10, 2011·Proceedings of the National Academy of Sciences of the United States of America·Ragna SannerudWim Annaert
Oct 1, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Joel JakobssonLennart Brodin
Jan 10, 2012·Cold Spring Harbor Perspectives in Medicine·Alberto Serrano-PozoBradley T Hyman
Feb 9, 2012·Cold Spring Harbor Perspectives in Medicine·Dennis SelkoeDavid Holtzman
May 4, 2012·Cold Spring Harbor Perspectives in Medicine·Christian HaassSangram Sisodia
Jul 5, 2012·Cold Spring Harbor Perspectives in Medicine·Lennart Mucke, Dennis J Selkoe
Mar 8, 2014·Neuroscience Letters·Jolanta L LundgrenSusanne Frykman

❮ Previous
Next ❯

Citations

Nov 9, 2016·Expert Opinion on Pharmacotherapy·Myuri RuthirakuhanKrista L Lanctôt
Sep 7, 2018·Experimental and Therapeutic Medicine·Wenting ZhangMinwu Xia
Jul 28, 2019·Medicinal Research Reviews·Nour M Moussa-PachaTaleb H Al-Tel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.